Areas of peer-reviewed scientific inquiry where this compound has appeared
Patients were excluded if they had a prescription fill within 60 days after the date of discontinuation or if the GLP-1 RA indication (AOM or ADM) could not be determined
The most common side effects of GLP-1 receptor agonists are gastrointestinal symptoms including nausea, vomiting, diarrhoea, and abdominal discomfort, particularly during treatment initiation
NSAIDs are known to cause gastric injury, and semaglutide delays stomach emptyinga mechanism that prolongs NSAID contact with the stomach lining
Retrieved from Rondanelli, M., Perna, S., Cattaneo, C., et al
This applies to adults with cardiovascular disease who are obese or overweight, and the approval is under the brand name Wegovy